Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | IMDZ | AQST | VRCA | ||
Company | Immune Design CS | Aquestive Therapeutics Inc | Verrica Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 5.84 | 4.00 | 6.62 | ||
High | 5.85 | 4.25 | 6.87 | ||
Low | 5.84 | 3.95 | 6.62 | ||
Last | 5.85 | 4.03 | 6.88 | ||
Change | unch | +0.10 | +0.23 | ||
% Change | unch | +2.54% | +3.46% | ||
Volume | 103,800 | 1,295,966 | 51,132 | ||
20-Day Average Volume | 409,005 | 2,376,218 | 177,331 | ||
Previous Close | 5.85 | 3.93 | 6.65 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 5.84 | 4.10 | 6.76 | ||
20-Day Raw Stochastic | 100.00% | 43.90% | 73.69% | ||
20-Day Relative Strength | 88.63% | 50.34% | 60.82% | ||
Weighted Alpha | -20.50 | +90.25 | +2.77 | ||
Today's Opinion | 88% Buy | 48% Buy | 100% Buy | ||
Previous Opinion | 88% Buy | 56% Buy | 88% Buy | ||
Last Month's Opinion | 56% Buy | 80% Buy | 80% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 03/25/19 | -0.61% since 04/19/24 | -1.69% since 04/19/24 | ||
Low | 5.84 on 04/01/19 | 3.78 on 04/25/24 | 6.57 on 04/22/24 | ||
High | 5.85 on 04/01/19 | 4.50 on 04/23/24 | 7.00 on 04/22/24 | ||
1-Month | |||||
%Chg | +0.34% since 03/01/19 | +0.49% since 03/26/24 | +28.99% since 03/26/24 | ||
Low | 5.82 on 03/14/19 | 3.72 on 04/16/24 | 5.28 on 03/27/24 | ||
High | 5.85 on 04/01/19 | 4.54 on 04/19/24 | 7.32 on 04/10/24 | ||
3-Month | |||||
%Chg | +350.00% since 12/31/18 | +70.71% since 01/26/24 | +18.52% since 01/26/24 | ||
Low | 1.22 on 01/03/19 | 2.36 on 01/29/24 | 4.60 on 03/20/24 | ||
High | 5.85 on 04/01/19 | 6.23 on 03/18/24 | 7.32 on 04/10/24 | ||
6-Month | |||||
%Chg | +73.08% since 10/01/18 | +189.36% since 10/26/23 | +95.50% since 10/26/23 | ||
Low | 1.10 on 12/24/18 | 1.38 on 10/27/23 | 2.86 on 11/14/23 | ||
High | 5.85 on 04/01/19 | 6.23 on 03/18/24 | 7.51 on 12/27/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 282,935 | 288,073 | 282,093 | ||
Shares Outstanding, K | 48,365 | 73,301 | 42,420 | ||
Annual Sales | 2,200,000 | 50,580,000 | 5,120,000 | ||
Annual Net Income | -54,760,000 | -7,870,000 | -67,000,000 | ||
Last Quarter Sales | 480,000 | 13,210,000 | 1,990,000 | ||
Last Quarter Net Income | -13,600,000 | -8,110,000 | -24,610,000 | ||
60-Month Beta | 3.48 | 2.87 | 1.88 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.12 on 03/05/24 | -0.48 on 02/29/24 | ||
Latest Earnings Date | 05/01/19 | 05/07/24 | 05/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |